Clinical efficacy of two different drug combinations for the treatment of canine leishmaniasis.
Pennisi
M G
MG
Dipartimento di Sanità Pubblica Veterinaria, Università degli Studi di Messina, Messina, Italy. mariagrazia.pennisi@unime.it
Lo Giudice
S
S
Masucci
M
M
De Majo
M
M
Reale
S
S
Vitale
F
F
D000818:Animals; D000913:Antibodies, Protozoan / Q000097:blood; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D004283:Dog Diseases / Q000188:drug therapy* / Q000469:parasitology*; D004285:Dogs; D004359:Drug Therapy, Combination; D007896:Leishmaniasis / Q000188:drug therapy / Q000662:veterinary*; D008536:Meglumine / Q000627:therapeutic use*; D000077485:Meglumine Antimoniate; D008795:Metronidazole / Q000627:therapeutic use*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D015572:Spiramycin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000913:Antibodies, Protozoan; D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008795:Metronidazole; D008536:Meglumine; D000077485:Meglumine Antimoniate; D015572:Spiramycin